TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2016 DA - 2016// TI - Cancer statistics, 2016 JO - CA Cancer J Clin VL - 66 UR - https://doi.org/10.3322/caac.21332 DO - 10.3322/caac.21332 ID - Siegel2016 ER - TY - JOUR AU - Ye, L. C. AU - Liu, T. S. AU - Ren, L. AU - Wei, Y. AU - Zhu, D. X. AU - Zai, S. Y. PY - 2013 DA - 2013// TI - Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.44.8308 DO - 10.1200/JCO.2012.44.8308 ID - Ye2013 ER - TY - JOUR AU - Amado, R. G. AU - Wolf, M. AU - Peeters, M. AU - Cutsem, E. AU - Siena, S. AU - Freeman, D. J. PY - 2008 DA - 2008// TI - Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.14.7116 DO - 10.1200/JCO.2007.14.7116 ID - Amado2008 ER - TY - JOUR AU - Maughan, T. S. AU - Adams, R. A. AU - Smith, C. G. AU - Meade, A. M. AU - Seymour, M. T. AU - Wilson, R. H. PY - 2011 DA - 2011// TI - Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial JO - Lancet VL - 377 UR - https://doi.org/10.1016/S0140-6736(11)60613-2 DO - 10.1016/S0140-6736(11)60613-2 ID - Maughan2011 ER - TY - JOUR AU - Nicolantonio, F. AU - Martini, M. AU - Molinari, F. AU - Sartore-Bianchi, A. AU - Arena, S. AU - Saletti, P. PY - 2008 DA - 2008// TI - Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2008.18.0786 DO - 10.1200/JCO.2008.18.0786 ID - Nicolantonio2008 ER - TY - JOUR AU - Roock, W. AU - Claes, B. AU - Bernasconi, D. AU - Schutter, J. AU - Biesmans, B. AU - Fountzilas, G. PY - 2010 DA - 2010// TI - Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis JO - Lancet Oncol VL - 11 UR - https://doi.org/10.1016/S1470-2045(10)70130-3 DO - 10.1016/S1470-2045(10)70130-3 ID - Roock2010 ER - TY - JOUR AU - Bertotti, A. AU - Migliardi, G. AU - Galimi, F. AU - Sassi, F. AU - Torti, D. AU - Isella, C. PY - 2011 DA - 2011// TI - A molecularly annotated platform of patient-derived xenografts (“xenopatients”) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer JO - Cancer Discov VL - 1 UR - https://doi.org/10.1158/2159-8290.CD-11-0109 DO - 10.1158/2159-8290.CD-11-0109 ID - Bertotti2011 ER - TY - JOUR AU - Bardelli, A. AU - Corso, S. AU - Bertotti, A. AU - Hobor, S. AU - Valtorta, E. AU - Siravegna, G. PY - 2013 DA - 2013// TI - Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer JO - Cancer Discov VL - 3 UR - https://doi.org/10.1158/2159-8290.CD-12-0558 DO - 10.1158/2159-8290.CD-12-0558 ID - Bardelli2013 ER - TY - JOUR AU - Qi, P. AU - Du, X. PY - 2013 DA - 2013// TI - The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine JO - Mod Pathol VL - 26 UR - https://doi.org/10.1038/modpathol.2012.160 DO - 10.1038/modpathol.2012.160 ID - Qi2013 ER - TY - JOUR AU - Mercer, T. R. AU - Dinger, M. E. AU - Mattick, J. S. PY - 2009 DA - 2009// TI - Long non-coding RNAs: insights into functions JO - Nat Rev Genet VL - 10 UR - https://doi.org/10.1038/nrg2521 DO - 10.1038/nrg2521 ID - Mercer2009 ER - TY - JOUR AU - Prensner, J. R. AU - Chinnaiyan, A. M. PY - 2011 DA - 2011// TI - The emergence of lncRNAs in cancer biology JO - Cancer Discov VL - 1 UR - https://doi.org/10.1158/2159-8290.CD-11-0209 DO - 10.1158/2159-8290.CD-11-0209 ID - Prensner2011 ER - TY - JOUR AU - Qu, L. AU - Ding, J. AU - Chen, C. AU - Wu, Z. J. AU - Liu, B. AU - Gao, Y. PY - 2016 DA - 2016// TI - Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA JO - Cancer Cell VL - 29 UR - https://doi.org/10.1016/j.ccell.2016.03.004 DO - 10.1016/j.ccell.2016.03.004 ID - Qu2016 ER - TY - JOUR AU - Qi, P. AU - Xu, M. D. AU - Ni, S. J. AU - Huang, D. AU - Wei, P. AU - Tan, C. PY - 2013 DA - 2013// TI - Low expression of LOC285194 is associated with poor prognosis in colorectal cancer JO - J Transl Med VL - 11 UR - https://doi.org/10.1186/1479-5876-11-122 DO - 10.1186/1479-5876-11-122 ID - Qi2013 ER - TY - JOUR AU - Qi, P. AU - Xu, M. D. AU - Ni, S. J. AU - Shen, X. H. AU - Wei, P. AU - Huang, D. PY - 2015 DA - 2015// TI - Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients JO - Mol Carcinog VL - 54 UR - https://doi.org/10.1002/mc.22137 DO - 10.1002/mc.22137 ID - Qi2015 ER - TY - JOUR AU - Xue, M. AU - Chen, W. AU - Li, X. PY - 2016 DA - 2016// TI - Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer JO - J Cancer Res Clin Oncol VL - 142 UR - https://doi.org/10.1007/s00432-015-2042-y DO - 10.1007/s00432-015-2042-y ID - Xue2016 ER - TY - JOUR AU - Han, Y. AU - Yang, Y. N. AU - Yuan, H. H. AU - Zhang, T. T. AU - Sui, H. AU - Wei, X. L. PY - 2014 DA - 2014// TI - UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution JO - Pathology VL - 46 UR - https://doi.org/10.1097/PAT.0000000000000125 DO - 10.1097/PAT.0000000000000125 ID - Han2014 ER - TY - JOUR AU - Wang, H. AU - Guan, Z. AU - He, K. AU - Qian, J. AU - Cao, J. AU - Teng, L. PY - 2017 DA - 2017// TI - LncRNA UCA1 in anti-cancer drug resistance JO - Oncotarget VL - 8 ID - Wang2017 ER - TY - JOUR AU - Dong, L. AU - Lin, W. AU - Qi, P. AU - Xu, M. D. AU - Wu, X. AU - Ni, S. PY - 2016 DA - 2016// TI - Circulating long RNAs in serum extracellular vesicles: their characterization and potential application as biomarkers for diagnosis of colorectal cancer JO - Cancer Epidemiol Biomark Prev VL - 25 UR - https://doi.org/10.1158/1055-9965.EPI-16-0006 DO - 10.1158/1055-9965.EPI-16-0006 ID - Dong2016 ER - TY - JOUR AU - Qi, P. AU - Zhou, X. Y. AU - Du, X. PY - 2016 DA - 2016// TI - Circulating long non-coding RNAs in cancer: current status and future perspectives JO - Mol Cancer VL - 15 UR - https://doi.org/10.1186/s12943-016-0524-4 DO - 10.1186/s12943-016-0524-4 ID - Qi2016 ER - TY - JOUR AU - Wang, J. AU - Liu, Y. AU - Sun, W. AU - Zhang, Q. AU - Gu, T. AU - Li, G. PY - 2018 DA - 2018// TI - Plasma exosomes as novel biomarker for the early diagnosis of gastric cancer JO - Cancer Biomark VL - 21 UR - https://doi.org/10.3233/CBM-170738 DO - 10.3233/CBM-170738 ID - Wang2018 ER - TY - JOUR AU - Tian, Y. AU - Li, S. AU - Song, J. AU - Ji, T. AU - Zhu, M. AU - Anderson, G. J. PY - 2014 DA - 2014// TI - A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy JO - Biomaterials VL - 35 UR - https://doi.org/10.1016/j.biomaterials.2013.11.083 DO - 10.1016/j.biomaterials.2013.11.083 ID - Tian2014 ER - TY - JOUR AU - Melo, S. A. AU - Sugimoto, H. AU - O’Connell, J. T. AU - Kato, N. AU - Villanueva, A. AU - Vidal, A. PY - 2014 DA - 2014// TI - Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis JO - Cancer Cell VL - 26 UR - https://doi.org/10.1016/j.ccell.2014.09.005 DO - 10.1016/j.ccell.2014.09.005 ID - Melo2014 ER - TY - JOUR AU - Peinado, H. AU - Alečković, M. AU - Lavotshkin, S. AU - Matei, I. AU - Costa-Silva, B. AU - Moreno-Bueno, G. PY - 2012 DA - 2012// TI - Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET JO - Nat Med VL - 18 UR - https://doi.org/10.1038/nm.2753 DO - 10.1038/nm.2753 ID - Peinado2012 ER - TY - JOUR AU - Bian, Z. AU - Jin, L. AU - Zhang, J. AU - Yin, Y. AU - Quan, C. AU - Hu, Y. PY - 2016 DA - 2016// TI - LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep23892 DO - 10.1038/srep23892 ID - Bian2016 ER - TY - JOUR AU - Fan, Q. AU - Yang, L. AU - Zhang, X. AU - Peng, X. AU - Wei, S. AU - Su, D. PY - 2018 DA - 2018// TI - The emerging role of exosome-derived non-coding RNAs in cancer biology JO - Cancer Lett VL - 414 UR - https://doi.org/10.1016/j.canlet.2017.10.040 DO - 10.1016/j.canlet.2017.10.040 ID - Fan2018 ER - TY - JOUR AU - Bobrie, A. AU - Krumeich, S. AU - Reyal, F. AU - Recchi, C. AU - Moita, L. F. AU - Seabra, M. C. PY - 2012 DA - 2012// TI - Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-12-0925 DO - 10.1158/0008-5472.CAN-12-0925 ID - Bobrie2012 ER - TY - JOUR AU - Webber, J. P. AU - Spary, L. K. AU - Sanders, A. J. AU - Chowdhury, R. AU - Jiang, W. G. AU - Steadman, R. PY - 2015 DA - 2015// TI - Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes JO - Oncogene VL - 34 UR - https://doi.org/10.1038/onc.2013.560 DO - 10.1038/onc.2013.560 ID - Webber2015 ER - TY - JOUR AU - Wang, J. AU - Hendrix, A. AU - Hernot, S. AU - Lemaire, M. AU - Bruyne, E. AU - Valckenborgh, E. PY - 2014 DA - 2014// TI - Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-03-562439 DO - 10.1182/blood-2014-03-562439 ID - Wang2014 ER - TY - JOUR AU - Shao, H. AU - Chung, J. AU - Lee, K. AU - Balaj, L. AU - Min, C. AU - Carter, B. S. PY - 2015 DA - 2015// TI - Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma JO - Nat Commun VL - 6 UR - https://doi.org/10.1038/ncomms7999 DO - 10.1038/ncomms7999 ID - Shao2015 ER - TY - JOUR AU - Zhang, L. AU - Pan, L. AU - Xiang, B. AU - Zhu, H. AU - Wu, Y. AU - Chen, M. PY - 2016 DA - 2016// TI - Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma JO - Oncotarget VL - 7 ID - Zhang2016 ER - TY - JOUR AU - Chen, Y. AU - Xie, Y. AU - Xu, L. AU - Zhan, S. AU - Xiao, Y. AU - Gao, Y. PY - 2017 DA - 2017// TI - Protein content and functional characteristics of serum-purified exosomes from patients with colorectal cancer revealed by quantitative proteomics JO - Int J Cancer VL - 140 UR - https://doi.org/10.1002/ijc.30496 DO - 10.1002/ijc.30496 ID - Chen2017 ER - TY - JOUR AU - Sugimachi, K. AU - Matsumura, T. AU - Hirata, H. AU - Uchi, R. AU - Ueda, M. AU - Ueo, H. PY - 2015 DA - 2015// TI - Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation JO - Br J Cancer VL - 112 UR - https://doi.org/10.1038/bjc.2014.621 DO - 10.1038/bjc.2014.621 ID - Sugimachi2015 ER - TY - JOUR AU - Ma, X. AU - Chen, Z. AU - Hua, D. AU - He, D. AU - Wang, L. AU - Zhang, P. PY - 2014 DA - 2014// TI - Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance JO - Proc Natl Acad Sci USA VL - 111 UR - https://doi.org/10.1073/pnas.1400272111 DO - 10.1073/pnas.1400272111 ID - Ma2014 ER - TY - JOUR AU - Kong, J. N. AU - He, Q. AU - Wang, G. AU - Dasgupta, S. AU - Dinkins, M. B. AU - Zhu, G. PY - 2015 DA - 2015// TI - Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells JO - Int J Cancer VL - 137 UR - https://doi.org/10.1002/ijc.29542 DO - 10.1002/ijc.29542 ID - Kong2015 ER - TY - JOUR AU - Wang, J. AU - Veirman, K. AU - Beule, N. AU - Maes, K. AU - Bruyne, E. AU - Valckenborgh, E. PY - 2015 DA - 2015// TI - The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells JO - Oncotarget VL - 6 ID - Wang2015 ER - TY - JOUR AU - Zhang, L. AU - Zhang, S. AU - Yao, J. AU - Lowery, F. J. AU - Zhang, Q. AU - Huang, W. C. PY - 2015 DA - 2015// TI - Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth JO - Nature VL - 527 UR - https://doi.org/10.1038/nature15376 DO - 10.1038/nature15376 ID - Zhang2015 ER - TY - JOUR AU - Wang, F. AU - Ying, H. Q. AU - He, B. S. AU - Pan, Y. Q. AU - Deng, Q. W. AU - Sun, H. L. PY - 2015 DA - 2015// TI - Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway JO - Oncotarget VL - 6 ID - Wang2015 ER - TY - JOUR AU - Nie, W. AU - Ge, H. J. AU - Yang, X. Q. AU - Sun, X. AU - Huang, H. AU - Tao, X. PY - 2016 DA - 2016// TI - LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p JO - Cancer Lett VL - 371 UR - https://doi.org/10.1016/j.canlet.2015.11.024 DO - 10.1016/j.canlet.2015.11.024 ID - Nie2016 ER - TY - JOUR AU - Xue, M. AU - Pang, H. AU - Li, X. AU - Li, H. AU - Pan, J. AU - Chen, W. PY - 2016 DA - 2016// TI - Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway JO - Cancer Sci VL - 107 UR - https://doi.org/10.1111/cas.12844 DO - 10.1111/cas.12844 ID - Xue2016 ER - TY - JOUR AU - Jiao, C. AU - Song, Z. AU - Chen, J. AU - Zhong, J. AU - Cai, W. AU - Tian, S. PY - 2016 DA - 2016// TI - lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer JO - Oncol Rep VL - 36 UR - https://doi.org/10.3892/or.2016.5121 DO - 10.3892/or.2016.5121 ID - Jiao2016 ER - TY - JOUR AU - Wang, T. AU - Yuan, J. AU - Feng, N. AU - Li, Y. AU - Lin, Z. AU - Jiang, Z. PY - 2014 DA - 2014// TI - Hsa-miR-1 downregulates long non-coding RNA urothelial cancer associated 1 in bladder cancer JO - Tumour Biol VL - 35 UR - https://doi.org/10.1007/s13277-014-2321-2 DO - 10.1007/s13277-014-2321-2 ID - Wang2014 ER - TY - JOUR AU - Li, X. AU - Wu, Y. AU - Liu, A. AU - Tang, X. PY - 2016 DA - 2016// TI - Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop JO - Tumour Biol VL - 37 UR - https://doi.org/10.1007/s13277-016-5348-8 DO - 10.1007/s13277-016-5348-8 ID - Li2016 ER - TY - JOUR AU - Xiao, Y. AU - Jiao, C. AU - Lin, Y. AU - Chen, M. AU - Zhang, J. AU - Wang, J. PY - 2017 DA - 2017// TI - lncRNA UCA1 contributes to imatinib resistance by acting as a ceRNA against miR-16 in chronic myeloid leukemia cells JO - DNA Cell Biol VL - 36 UR - https://doi.org/10.1089/dna.2016.3533 DO - 10.1089/dna.2016.3533 ID - Xiao2017 ER - TY - JOUR AU - Cheng, N. AU - Cai, W. AU - Ren, S. AU - Li, X. AU - Wang, Q. AU - Pan, H. PY - 2015 DA - 2015// TI - Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.4361 DO - 10.18632/oncotarget.4361 ID - Cheng2015 ER - TY - JOUR AU - Fan, Y. AU - Shen, B. AU - Tan, M. AU - Mu, X. AU - Qin, Y. AU - Zhang, F. PY - 2014 DA - 2014// TI - Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling JO - FEBS J VL - 281 UR - https://doi.org/10.1111/febs.12737 DO - 10.1111/febs.12737 ID - Fan2014 ER - TY - JOUR AU - Shang, C. AU - Guo, Y. AU - Zhang, J. AU - Huang, B. PY - 2016 DA - 2016// TI - Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer JO - Cancer Chemother Pharmacol VL - 77 UR - https://doi.org/10.1007/s00280-016-3029-3 DO - 10.1007/s00280-016-3029-3 ID - Shang2016 ER -